Iranian researchers test gold nanoparticle cancer drug delivery

Nanomedicine researchers at Lorestan University in Iran say they've made progress with a new drug delivery mechanism designed to carry targeted non-chemotherapy cancer treatments. Their design calls for loading the anti-cancer drug onto a gold nanomaterial and then covering it with polymer nanolayers, the Iranian Students' News Agency reports. This process, they report, is designed to use the gold to transfer a specific light wavelength to heat. That, in turn, destroys the nanostructure layers and releases the medicine at a specific target. So far, early tests have allowed the special drug to smash cancer cells without hurting healthy tissue, unlike chemotherapy. Story

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.